Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 16,288 | 15,971 | 16,373 | 17,788 | 16,608 |
| Gross Profit | 16,288 | 15,971 | 16,373 | 17,788 | 16,608 |
| Operating Expenses | 35,493 | 31,598 | 31,152 | 32,683 | 32,746 |
| Operating Income | -19,205 | -15,627 | -14,779 | -14,895 | -16,138 |
| Other Income | -38 | 73 | 78 | 185 | 459 |
| Pre-tax Income | -19,243 | -15,554 | -14,701 | -14,710 | -15,679 |
| Net Income Continuous | -19,243 | -15,554 | -14,701 | -14,710 | -15,679 |
| Net Income | $-19,243 | $-15,554 | $-14,701 | $-14,710 | $-15,679 |
| EPS Basic Total Ops | -0.30 | -0.26 | -0.32 | -0.32 | -0.34 |
| EPS Basic Continuous Ops | -0.30 | -0.26 | -0.32 | -0.32 | -0.34 |
| EPS Diluted Total Ops | -0.30 | -0.26 | -0.31 | -0.32 | -0.34 |
| EPS Diluted Continuous Ops | -0.30 | -0.26 | -0.31 | -0.32 | -0.34 |
| EBITDA(a) | $-18,388 | $-14,812 | $-14,012 | $-14,270 | $-15,703 |